Showing results (1771-1780 of 1,827) with videos related to
Sort By:
Pageof 183
Neuron|June 14, 2023
An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathologyPatrick W Sheehan, Collin J Nadarajah, Michael F Kanan, et al.Nature Biotechnology|January 14, 2022
Cell2location maps fine-grained cell types in spatial transcriptomicsVitalii Kleshchevnikov, Artem Shmatko, Emma Dann, et al.Nature Chemical Biology|April 11, 2017
Mechanistic insights into energy conservation by flavin-based electron bifurcationCarolyn E Lubner, David P Jennings, David W Mulder, et al.The Journal of the American Osteopathic Association|April 30, 2014
Wikipedia vs peer-reviewed medical literature for information about the 10 most costly medical conditionsRobert T Hasty, Ryan C Garbalosa, Vincenzo A Barbato, et al.Journal of Medicinal Chemistry|October 15, 2021
Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation In VivoJ Howard Jones, Zhili Xin, Martin Himmelbauer, et al.Nature Communications|July 7, 2026
Primary sclerosing cholangitis displays distinct colonic mucosa topography yet a shared mast cell state with ulcerative colitisJacqueline LE Tearle, Ekaterina Sviriaeva, Fan Zhang, et al.Mbio|March 8, 2018
IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Salmonella Develop at Discordant RatesAnna E Schager, C Coral Dominguez-Medina, Francesca Necchi, et al.Academic Medicine : Journal of the Association of American Medical Colleges|March 6, 2020
The Harvard Medical School Pathways Curriculum: Reimagining Developmentally Appropriate Medical Education for Contemporary LearnersRichard M Schwartzstein, Jules L Dienstag, Randall W King, et al.Cell|January 12, 2019
Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the LungKristopher R Genschmer, Derek W Russell, Charitharth Lal, et al.Hepatology (Baltimore, Md.)|April 14, 2011
Racial differences in hepatitis C treatment eligibilityMichael T Melia, Andrew J Muir, Jonathan McCone, et al.Pageof 183